Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Abbott receives CE Mark for cytomegalovirus testing device

Abbott receives CE Mark for cytomegalovirus testing device

27th May 2011

Abbott has been granted European CE Mark approval for a new testing system for cytomegalovirus (CMV) DNA quantitation.

The RealTime polymerase chain reaction molecular diagnostic test is designed for use with the Abbott m2000 DNA and RNA testing system and is designed to help in the detection of the single most common viral infection among transplant recipients.

Abbott's device can be used to identify CMV DNA in human plasma or whole blood, offering superior accuracy and precision to serological tests.

It can be used both as an indicator to initiate therapy and to help monitor viral response to antiviral treatments, in conjunction with clinical presentation and other lab markers.

Kristina Rodnikova, divisional vice-president and general manager of Abbott's European molecular diagnostics business, said: "The automation of the m2000 system and the high reproducibility of the Abbott RealTime CMV assay can provide rapid and reliable information to help clinicians make treatment decisions."

This comes after the company received CE Mark approval for FreeStyle InsuLinx, a new blood glucose monitoring system for diabetes patients, earlier this month.ADNFCR-8000103-ID-800559988-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.